Quarterly report pursuant to Section 13 or 15(d)

STOCKBASED COMPENSATION (Tables)

v3.21.2
STOCKBASED COMPENSATION (Tables)
9 Months Ended
Sep. 30, 2021
STOCK-BASED COMPENSATION  
Schedule of Equity incentive plan

 

 

Awards Reserved for Issuance

 

 

Awards Outstanding

 

 

 

 

 

 

 

 

2016 Equity incentive plan

 

 

2,000,000

 

 

 

499,953

 

2018 Equity incentive plan

 

 

43,976,425

 

 

 

20,665,587

 

Schedule of Stock option activity

 

 

Number of Shares

 

 

Weighted-Average Exercise Price Per Share

 

 

Weighted-Average Remaining Contractual Life

 

Aggregate Intrinsic Value of In-the-Money Options

 

 

 

 

 

 

 

 

Options outstanding as of January 1, 2021

 

 

17,492,830

 

 

$ 0.41

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options granted

 

 

88,930,019

 

 

$ 0.23

 

 

 

 

 

 

Options exercised

 

 

(2,096,970 )

 

$ 0.05

 

 

 

 

 

 

Options forfeited

 

 

(4,584,010 )

 

$ 0.19

 

 

 

 

 

 

Options expired

 

 

-

 

 

$ -

 

 

 

 

 

 

Options outstanding as of September 30, 2021

 

 

99,741,869

 

 

$ 0.46

 

 

9.0 years

 

$ 2,797

 

Options exercisable as of September 30, 2021

 

 

5,593,814

 

 

$ 0.91

 

 

8.4 years

 

$ 1,390

 

Schedule of Stock based compensation assumptions

 

 

(in thousands except for shares / options)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

For the Three Months Ended

 

 

 

September 30, 2021

 

 

September 30, 2020

 

Type of Award

 

Number of Shares or Options Granted

 

 

Stock-Based Compensation Expense

 

 

Number of Shares or Options Granted

 

 

Stock-Based Compensation Expense

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock options

 

 

83,020,303

 

 

$ 780

 

 

 

909,090

 

 

$ 298

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock grants:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Employees (common stock)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Directors (common stock)

 

 

-

 

 

 

-

 

 

 

1,082,700

 

 

 

119

 

Non–employee consultants (common stock)

 

 

-

 

 

 

-

 

 

 

84,615

 

 

 

11

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total stock–based compensation expense

 

 

 

 

 

$ 780

 

 

 

 

 

 

$ 428

 

 

 

 

For the Nine Months Ended

 

 

 

September 30, 2021

 

 

September 30, 2020

 

Type of Award

 

Number of Shares or Options Granted

 

 

Stock-Based Compensation Expense

 

 

Number of Shares or Options Granted

 

 

Stock-Based Compensation Expense

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock options

 

 

88,930,019

 

 

$ 1,664

 

 

 

10,559,090

 

 

$ 1,536

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock grants:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Employees (common stock)

 

 

250,000

 

 

 

67

 

 

 

3,179,544

 

 

 

58 (a)

Directors (common stock)

 

 

885,159

 

 

 

213

 

 

 

909,090

 

 

 

19 (b)

Non–employee consultants (common stock)

 

 

322,947

 

 

 

32

 

 

 

1,159,615

 

 

 

59

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total stock–based compensation expense

 

 

 

 

 

$ 1,976

 

 

 

 

 

 

$ 1,672

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(a) Expense for Q1 grants attributed to 2019 bonuses was recorded in 2019.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(b) clawback of shares granted in 2019.